Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

As AI, model-based systems engineering and digital thread strategies evolve, they're transforming how organizations define ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

A terrific indication of AI’s promise is the 2024 Nobel Prize in chemistry, winners of which used AI to “crack the code” of ...

U.S. President Donald Trump is slated to deliver a message outlining his vision for America's role in the development of ...

Google, Meta, and CoreWeave lead an expected $90 billion wave of AI and energy investments in Pennsylvania, marking a shift ...

Healthcare product development is undergoing a major transformation, driven by technologies like AI, ML, and IoMT. These ...

The failure to enact a proposed 10-year moratorium on state AI regulations brings meaningful clarity for employers, according ...

As technology continues to reshape financial services, regulators and policy setters are embarking on a range of ...